Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 DeFi Kingdoms DeFi Kingdoms +1,091.75%
#4 Black Phoenix Black Phoenix +335.99%
#5 aPriori aPriori +116.11%
#6 Bedrock Bedrock +74.68%
#7 Cysic Cysic +47.27%
#8 Prom Prom +42.47%
#9 Playnance Playnance +34.82%
#10 COTI COTI +30.34%
Coin of the day
Wrapped One Wrapped One
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Fresh2 Group Limited Fresh2 Group Limited

Fresh2 Group Limited

FRES
Classement en actions #42683
Fresh2 Group Limited, a biotechnology company established in New York, New... Fresh2 Group Limited, a biotechnology company established in New York, New York, in 2010, officially adopted its current name in April 2023, having previously been known as AnPac Bio-Medical Science Co., Ltd. The company is primarily engaged in the research, development, promotion, and sale of advanced multi-cancer screening and detection tests within the People's Republic of China, leveraging its proprietary cancer differentiation analysis (CDA) technology and associated devices for corporate and life insurance clients. Beyond these core diagnostic offerings, Fresh2 Group provides comprehensive physical checkup packages and an array of technology services, including market research, design, software coding, development, and testing. The company also markets genetic testing kits and various skincare products. It owns several fundamental technology platforms and actively participates in further technological innovation and product distribution. Adding a unique dimension to its operations, Fresh2 Group also manages an e-commerce platform that facilitates connections between food suppliers and both supermarket operators and restaurant owners.
Prix de l'action
$0.85
Dernière synchronisation: 2025-01-21
Capitalisation boursière
$411.40
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Fresh2 Group Limited (FRES)

Catégorie

Healthcare
Revenus pour Fresh2 Group Limited (FRES)
Revenus en Jun 2023 TTM : $1.64M
Selon les derniers rapports financiers de Fresh2 Group Limited, le chiffre d'affaires actuel de l'entreprise (TTM) est de $1.64M. En 2021, l'entreprise a réalisé un chiffre d'affaires de $2.79M une diminution par rapport à le chiffre d'affaires de l'année 2020, qui était de $2.97M. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Fresh2 Group Limited de 2017 à 2026
Revenus à la fin de chaque année
Année Revenus Changez
2026 (TTM) $1.64M -5.98%
2022 $1.75M -37.49%
2021 $2.79M -5.89%
2020 $2.97M 91.09%
2019 $1.55M 0.32%
2018 $1.55M 81.73%
2017 $851.95K 0.00%
Revenus d’entreprises similaires ou concurrentes
Entreprise Revenus Différence de revenus Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 768,932.17%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 366,697.66%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B 615,816.94%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR